Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH) is a publicly traded Healthcare sector company. As of August 12, 2026, RVPH trades at $0.35 with a market cap of $10.19M and a P/E ratio of -0.06. RVPH moved -55.76% today. Year to date, RVPH is -94.32%; over the trailing twelve months it is -97.89%. Its 52-week range spans $0.26 to $85.60. Analyst consensus is buy with an average price target of $15.50. Rallies surfaces RVPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Reviva Pharmaceuticals Holdings, Inc. Common Stock (RVPH) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RVPH moved -55.76% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.35 |
| Market Cap | $10.19M |
| P/E Ratio | -0.06 |
| EPS | $-5.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.60 |
| 52-Week Low | $0.26 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-19.86M |
| Gross Margin | 0.00% |
4 analysts cover RVPH: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.50.